Targeting MDM2 affects spastin protein levels and functions: implications for HSP treatment
Abstract Spastin is a microtubule (MT) severing enzyme that regulates several cell functions associated with MT dynamics. A reduction in spastin protein levels is responsible for approximately 40% of cases of Hereditary Spastic Paraplegia (HSP), a neurodegenerative disease. Currently, there is no cu...
Saved in:
Main Authors: | Francesca Sardina, Federica Polverino, Sonia Valentini, Claudia Carsetti, Elisabetta Falvo, Giada Tisci, Silvia Soddu, Fabiola Moretti, Alessandro Paiardini, Cinzia Rinaldo |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-02-01
|
Series: | Cell Death Discovery |
Online Access: | https://doi.org/10.1038/s41420-025-02333-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MDM4 Isoform Expression in Melanoma Supports an Oncogenic Role for MDM4-A
by: Abdullah Alatawi, et al.
Published: (2021-01-01) -
Targeted allele-specific FGFR2 knockdown via human recombinant ferritin nanoparticles for personalized treatment of Crouzon syndrome
by: Federica Tiberio, et al.
Published: (2025-03-01) -
Identification and expression analysis of the heat shock proteins Hsp70, Hsp90, and Hsp90b in Litopenaeus vannamei under low-temperature stress
by: Min Peng, et al.
Published: (2025-03-01) -
Hsp27-Actin Interaction
by: Philip Graceffa
Published: (2011-01-01) -
The known unknowns of the Hsp90 chaperone
by: Laura-Marie Silbermann, et al.
Published: (2024-12-01)